ArticleMolecules (Basel, Switzerland)2021

First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease.

Rosa Purgatorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.